Editorial
When the inhibitor is turned into stimulator: novel aspects in T cell engineering
Abstract
The therapeutic use of T cells for tumor immunotherapy encompasses isolation of T cells from the patient, arming T cells with a receptor conferring tumor-specificity and reinfusion to the patient (1).
